Tesamorelin

4 articles in this topic.

Complete Guides

Tesamorelin (Egrifta): The FDA-Approved GHRH Analog

Tesamorelin is the only FDA-approved GHRH analog for HIV lipodystrophy. Clinical trial data on visceral fat, liver fat, cognition, and emerging research.

17 min read|Mar 20, 2026

All Articles

Tesamorelin

Tesamorelin's Cognitive Effects: An Unexpected Finding

A 20-week RCT found tesamorelin improved executive function in MCI and healthy older adults while raising brain GABA levels. Here is the cognitive evidence.

12 min read|Mar 25, 2026

Tesamorelin

Tesamorelin and HIV Lipodystrophy

Tesamorelin reduced visceral fat by 15-20% in HIV patients with lipodystrophy. Here is the clinical evidence behind the only FDA-approved GHRH analog.

13 min read|Mar 25, 2026

Tesamorelin

Tesamorelin and Liver Fat: MASH Research

Tesamorelin reduced liver fat by 37% and halved fibrosis progression in HIV-associated NAFLD trials. What this GHRH analog means for broader MASH treatment.

11 min read|Mar 25, 2026